医学
肺结核
多重耐药
直接观察疗法
重症监护医学
抗药性
病理
微生物学
生物
作者
Aliaksandr Skrahin,Helen E. Jenkins,Henadz Hurevich,Varvara Solodovnikova,Yanina Isaikina,Dzmitri Klimuk,Zoya Rohava,Alena Skrahina
标识
DOI:10.1016/j.jctube.2016.05.003
摘要
MSC treatment could vastly improve treatment outcomes for MDR-TB patients. Our findings could revolutionize therapy options and have strong implications for future directions of MDR-TB therapy research.
科研通智能强力驱动
Strongly Powered by AbleSci AI